Nanobiotix S.A. will participate in the H.C. Wainwright Annual Global Investment Conference on September 15, 2026, in New York. CEO Laurent Lévy and Chief Financial and Business Officer Bart Van Rhijn will present, giving investors a scheduled management forum focused on the company.

Key Highlights

  • Laurent Lévy and Bart Van Rhijn will represent Nanobiotix at the conference.
  • The presentation will take place in New York.
  • Nanobiotix will participate in the H.C. Wainwright Annual Global Investment Conference on September 15, 2026.
  • Management will take part in a fireside chat in New York.

Nanobiotix S.A. (NASDAQ: NBTX) will participate in the H.C. Wainwright Annual Global Investment Conference on September 15, 2026. The company’s management will take part in a fireside chat, giving investors a scheduled opportunity to hear directly from its senior executives.

Management Set

for New York Conference The event will be held in New York, where Nanobiotix will be represented by Chief Executive Officer Laurent Lévy and Chief Financial and Business Officer Bart Van Rhijn. The appearance is part of the company’s investor conference program. The company was incorporated in 2003, began trading on Euronext Paris in 2012 and has been listed on Nasdaq since December 2020. Nanobiotix also said it owns more than 30 umbrella patents linked to three nanotechnology platforms covering oncology, bioavailability and biodistribution, and central nervous system disorders.